A ventricular septal defect (VSD), a hole in the heart, is a common heart defect that's present at birth (congenital). The hole occurs in the wall that separates the heart's lower chambers (septum) and allows blood to pass from the left to the right side of the heart. The oxygen-rich blood then gets pumped back to the lungs instead of out to the body, causing the heart to work harder. VSD closure devices are intended to close openings between lower chambers.VSD closure devices have the same usage with ASD closure devices.

Market Analysis and Insights: Global VSD Closure Devices Market
The global VSD Closure Devices market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global VSD Closure Devices Scope and Market Size
The global VSD Closure Devices market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global VSD Closure Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Stainless Steel
Titanium
Others

Segment by Application
Hospitals
Clinics
Others

The VSD Closure Devices market is analysed and market size information is provided by regions (countries). Segment by Application, the VSD Closure Devices market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Abbott
Boston Scientific Corp
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort